![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/28 | (2006.01) |
A61P 5/48 | (2006.01) | ||
A61K 33/30 | (2006.01) | ||
A61K 47/10 | (2017.01) |
(11) | Number of the document | 3554534 |
(13) | Kind of document | T |
(96) | European patent application number | 17832941.3 |
Date of filing the European patent application | 2017-12-15 | |
(97) | Date of publication of the European application | 2019-10-23 |
(45) | Date of publication and mention of the grant of the patent | 2021-06-23 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2017/083013 |
Date | 2017-12-15 |
(87) | Number | WO 2018/109162 |
Date | 2018-06-21 |
(30) | Number | Date | Country code |
16204688 | 2016-12-16 | EP |
(72) |
NORRMAN, Mathias , DK
HOSTRUP, Susanne , DK
STEENSGAARD, Dorte, Bjerre , DK
STRAUSS, Holger, Martin , DK
HANSEN, Rosa, Rebecca, Erritzøe , DK
HAVELUND, Svend , DK
SCHLEIN, Morten , DK
PEDERSEN, Jesper, Søndergaard , DK
|
(73) |
Novo Nordisk A/S ,
Novo Allé, 2880 Bagsværd,
DK
|
(54) | INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS |
INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS |